0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Special Feature |  FREE
Megan Steigelman, MD; Matthew Chauviere, MD
Arch Surg. 2012;147(5):483. doi:10.1001/archsurg.2011.948a.

Special Feature |  FREE
Arch Surg. 2008;143(12):1232. doi:10.1001/archsurg.143.12.1232.

Basic Science Review | 
Nirmal K. Veeramachaneni, BS; Alden H. Harken, MD; Charles B. Cairns, MD
Arch Surg. 1999;134(4):434-437. doi:10.1001/archsurg.134.4.434.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA
Health Agencies Update  | 
Sickle Cell Drug Candidate Under Development
Tracy Hampton, PhD
JAMA
Editorial  | 
Reconsideration of Age as a Contraindication for Curative Therapy of Sickle Cell Disease
Allison A. King, MD, MPH; John F. DiPersio, MD, PhD
JAMA
Original Investigation  | 
Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype
Matthew M. Hsieh, MD; Courtney D. Fitzhugh, MD; R. Patrick Weitzel, PhD; et al.
JAMA
Viewpoint  | 
Sickle Cell Trait—Neglected Opportunities in the Era of Genomic Medicine
Catherine Taylor, MB, BChir; Patricia Kavanagh, MD; Barry Zuckerman, MD